Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...
Nursing home patients with HIV tend to be younger. They also typically have more comorbidities than the average patient, and ...
New EACS 2025 data show once-weekly islatravir and lenacapavir maintain HIV viral suppression for 96 weeks with no resistance ...
HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as ...
ViiV Healthcare, a healthcare company founded by Pfizer (NYSE:PFE) and GSK (NYSE:GSK), announced on Wednesday that its ...
This article originally appeared on Out: ‘Boss & CEO’ TikTok creator reveals HIV diagnosis, crowdfunds for meds Notre Dame ...
South Africa’s fight against HIV/AIDS has received a boost with the USA government’s approval of the US President’s Emergency ...
1don MSN
New study finds skin conditions remain prevalent in people with HIV despite advances in treatment
A new study led by researchers at the George Washington University and published through the DC Cohort, one of the largest HIV longitudinal studies in the United States, finds that nearly half of ...
As many as 70% of those living with HIV are expected to be 50 or older by 2030. They often need skilled nursing earlier than ...
Community advocates, health providers and local leaders in Charleston are all joining forces Wednesday in observance of ...
In the wake of massive U.S. cuts to foreign aid, the tiny country of Lesotho in southern Africa faces deep uncertainty and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback